Meeting highlights: International consensus panel on the treatment of primary breast cancer

J Clin Oncol. 2002 Apr 1;20(7):1955-6; author reply 1956-7. doi: 10.1200/JCO.2002.20.7.1955.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism
  • Chemotherapy, Adjuvant
  • Cisplatin / administration & dosage
  • Clinical Trials as Topic
  • Consensus Development Conferences as Topic
  • Disease-Free Survival
  • Estrogen Receptor Modulators / therapeutic use*
  • Female
  • Fluorouracil / administration & dosage
  • Gonadotropin-Releasing Hormone / agonists*
  • Humans
  • Methotrexate / administration & dosage
  • Middle Aged
  • Ovariectomy*
  • Premenopause
  • Survival Analysis
  • Tamoxifen / therapeutic use*
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Hormonal
  • Estrogen Receptor Modulators
  • Tamoxifen
  • Gonadotropin-Releasing Hormone
  • Cisplatin
  • Fluorouracil
  • Methotrexate

Supplementary concepts

  • CMF protocol